Longitudinal Bladder Cancer Study for Tumour Recurrence

计划入组 450 人 · 首次发布于 2021 年 10 月 18 日

The Cxbladder Monitoring Study

计划入组 803 人 · 首次发布于 2016 年 3 月 7 日

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

计划入组 107 人 · 首次发布于 2023 年 11 月 13 日

Methamidophos

C₂H₈NO₂PS

Oportuzumab monatox

Bladder Cancer(Biomics Biotechnologies)

JEVA LABORATORIES PTY LTD

Australia

VentriPoint Diagnostics Ltd

Pebblebrook Hotel Trust

United States

Cxbladder Test Evaluated for Urothelial Carcinoma Surveillance in LOBSTER Study

Codex Genetics Partners with Pacific Edge to Bring Non-Invasive Bladder Cancer Testing to Hong Kong

Pacific Edge's Cxbladder Triage Test Incorporated Into AUA Microhematuria Guidelines as Only Biomarker with Grade A Evidence